| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.09 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.051 | 0.09 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.09 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.09 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |